168 related articles for article (PubMed ID: 2248955)
1. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor.
Komiyama Y; Pedersen AH; Kisiel W
Biochemistry; 1990 Oct; 29(40):9418-25. PubMed ID: 2248955
[TBL] [Abstract][Full Text] [Related]
2. Extrinsic activation of human coagulation factors IX and X on the endothelial surface.
Bom VJ; van Hinsbergh VW; Reinalda-Poot HH; Mohanlal RW; Bertina RM
Thromb Haemost; 1991 Sep; 66(3):283-91. PubMed ID: 1745998
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of recombinant human blood coagulation factor VIIa amidolytic and proteolytic activity by zinc ions.
Pedersen AH; Lund-Hansen T; Komiyama Y; Petersen LC; Oestergård PB; Kisiel W
Thromb Haemost; 1991 May; 65(5):528-34. PubMed ID: 1871714
[TBL] [Abstract][Full Text] [Related]
4. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.
Bom VJ; Bertina RM
Biochem J; 1990 Jan; 265(2):327-36. PubMed ID: 2302175
[TBL] [Abstract][Full Text] [Related]
5. [Activation of factors IX and X by factor VIIa].
Komiyama Y
Rinsho Byori; 1992 Mar; Suppl 92():73-82. PubMed ID: 1583779
[No Abstract] [Full Text] [Related]
6. A candidate activation pathway for coagulation factor VII.
Misenheimer TM; Kumfer KT; Bates BE; Nettesheim ER; Schwartz BS
Biochem J; 2019 Oct; 476(19):2909-2926. PubMed ID: 31537632
[TBL] [Abstract][Full Text] [Related]
7. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.
Repke D; Gemmell CH; Guha A; Turitto VT; Broze GJ; Nemerson Y
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7623-7. PubMed ID: 2120704
[TBL] [Abstract][Full Text] [Related]
8. Properties of factor VIIa/tissue factor complexes in an umbilical vein model.
Almus FE; Rao LV; Fleck RA; Rapaport SI
Blood; 1990 Jul; 76(2):354-60. PubMed ID: 2114934
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
10. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation.
Lawson JH; Mann KG
J Biol Chem; 1991 Jun; 266(17):11317-27. PubMed ID: 2040636
[TBL] [Abstract][Full Text] [Related]
11. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.
Mertens K; Bertina RM
Biochem J; 1984 Nov; 223(3):607-15. PubMed ID: 6334517
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
Almus FE; Rao LV; Rapaport SI
Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
[TBL] [Abstract][Full Text] [Related]
13. Extrinsic activation of human blood coagulation factors IX and X.
Bom VJ; Reinalda-Poot JH; Cupers R; Bertina RM
Thromb Haemost; 1990 Apr; 63(2):224-30. PubMed ID: 2363125
[TBL] [Abstract][Full Text] [Related]
14. Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: a kinetic study.
Rao LV; Robinson T; Hoang AD
Thromb Haemost; 1992 Jun; 67(6):654-9. PubMed ID: 1509405
[TBL] [Abstract][Full Text] [Related]
15. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
Kondo S; Kisiel W
Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
[TBL] [Abstract][Full Text] [Related]
16. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor.
ten Cate H; Bauer KA; Levi M; Edgington TS; Sublett RD; Barzegar S; Kass BL; Rosenberg RD
J Clin Invest; 1993 Sep; 92(3):1207-12. PubMed ID: 8376580
[TBL] [Abstract][Full Text] [Related]
17. Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.
Dittmar S; Ruf W; Edgington TS
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):787-93. PubMed ID: 9032467
[TBL] [Abstract][Full Text] [Related]
18. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
19. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
Zhong D; Smith KJ; Birktoft JJ; Bajaj SP
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3574-8. PubMed ID: 8170949
[TBL] [Abstract][Full Text] [Related]
20. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
